At the coalface--medical ethics in practice. First, do no harm

Area of Science:

• Medical ethics
• Clinical research methodology
• Patient safety

Background:

• Physicians often serve dual roles as clinicians and researchers.
• Clinical trials frequently employ blinding to prevent bias.
• Blinding requires researchers to withhold treatment information from participants and often clinicians.

Observation:

• Mrs. W presented with new medical issues during a clinical trial.
• Her physician was blinded to whether she was receiving the active drug or a placebo.
• This created uncertainty regarding the cause of her symptoms.

Findings:

• The physician's inability to ascertain the treatment allocation complicated diagnosis.
• Differentiating between drug side effects and unrelated medical conditions became challenging.
• The case highlights a potential conflict between research integrity and immediate patient care.

Implications:

• Physician-researchers must navigate ethical considerations in blinded studies.
• Protocols may need to address mechanisms for managing patient safety concerns in blinded trials.
• The findings underscore the importance of balancing research objectives with the physician's duty to the patient.